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Introduction: Non-transformed mammary epithelial cell lines such as MCF-10A recapitulate epithelial
morphogenesis in three-dimensional (3D) tissue culture by forming acinar structures. They represent an important
tool to characterize the biological properties of oncogenes and to model early carcinogenic events. So far,
however, these approaches were restricted to cells with constitutive oncogene expression prior to the set-up of 3D
cultures. Although very informative, this experimental setting has precluded the analysis of effects caused by
sudden oncoprotein expression or withdrawal in established epithelial cultures. Here, we report the establishment
and use of a stable MCF-10A cell line (MCF-10Atet) fitted with a novel and improved doxycycline (dox)-regulated
expression system allowing the conditional expression of any transgene.
Methods: MCF-10Atet cells were generated by stable transfection with pWHE644, a vector expressing a second
generation tetracycline-regulated transactivator and a novel transcriptional silencer. In order to test the properties of
this new repressor/activator switch, MCF-10Atet cells were transfected with a second plasmid, pTET-HABRAF-IRES-GFP,
which responds to dox treatment with the production of a bi-cistronic transcript encoding hemagglutinin-tagged B-Raf
and green fluorescent protein (GFP). This improved conditional expression system was then characterized in detail in
terms of its response to various dox concentrations and exposure times. The plasticity of the phenotype provoked by
oncogenic B-Raf
V600E in MCF-10Atet cells was analyzed in 3D cultures by dox exposure and subsequent wash-out.
Results: MCF-10Atet cells represent a tightly controlled, conditional gene expression system. Using B-Raf
V600E as a
model oncoprotein, we show that its sudden expression in established 3D cultures results in the loss of acinar
organization, the induction of an invasive phenotype and hallmarks of epithelial-to-mesenchymal transition (EMT).
Importantly, we show for the first time that this severe transformed phenotype can be reversed by dox wash-out
and concomitant termination of oncogene expression.
Conclusions: Taken together, we have generated a stable MCF-10A subline allowing tight dox-controlled and
reversible expression of any transgene without the need to modify its product by introducing artificial dimerization
or ligand-binding domains. This system will be very valuable to address phenomena such as EMT, oncogene
addiction, oncogene-induced senescence and drug resistance.
Keywords: MCF-10A, mammary epithelium, carcinogenesis, BRAF, epithelial-mesenchymal transition (EMT), tetracy-
cline-inducible gene expression system, apoptosis, E-Cadherin, KI-67, Caspase-3
Background
The majority of human cancers (carcinomas), including
breast cancer, are caused by the malignant transforma-
tion of epithelial cells [1]. Epithelia form well-ordered
sheets with well-defined planar and apico-basal polarity
axes [2,3]. As they are surrounded by a basal lamina,
they constitute a critical barrier between the internal
m i l i e uo ft h eb o d ya n dt h ee x t e r i o rs p a c e .T h e ya l s o
separate the secretory from the stromal compartment in
glandular tissues such as the breast, prostate or pan-
creas. The proper orchestration of proliferation and dif-
ferentiation processes as well as the development of the
aforementioned polarity axes is key to the biological
functions of epithelia. Conversely, the progressive loss of
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any medium, provided the original work is properly cited.this well-ordered architecture is a hallmark of tumors of
epithelial origin and has been used by pathologists for
carcinoma classification since decades. Until recently,
cell biologists have studied the architecture and differen-
tiation of epithelia either in vivo or have resorted to in
vitro model systems in which epithelial cells were grown
as a monolayer on artificial surfaces such as plastic cul-
ture dishes. Notably, not more than a decade ago, sev-
eral laboratories studying epithelial cells and their
transformed counterparts began to grow epithelial cells
in three-dimensional (3D) culture systems, which recapi-
tulate many facets of epithelial tissues in vivo [1,4-6].
For example, the immortalized, non-transformed cell
line MCF-10A retains the intrinsic ability of mammary
epithelial cells (MECs) to undergo acinar morphogenesis
in 3D matrigel cultures, a process that relies on growth-
factor-dependent proliferation, the induction of luminal
programmed cell death, establishment of an apico-basal
polarity axis and the deposition of a basal lamina
[1,3,7,8]. Studies from various laboratories have shown
that various oncogenes can have distinct perturbing
effects on acinar morphogenesis and induce supra-cellu-
lar effects in the cell colonies, which are also observed
by pathologists in neoplastic lesions such as ductal car-
cinoma in situ (DCIS) [1]. For example, purely “prolif-
erative” oncogenes enhance acinar size, while mainly
“anti-apoptotic” oncogenes block or delay luminal clear-
ance [7,9]. Very potent oncogenes such as activated
forms of the receptor tyrosine kinase (RTK) HER2/
ErbB2 impinge on multiple aspects of acinus develop-
ment by enhancing not only the proliferation of onco-
gene-expressing cells, but also by blocking luminal cell
death and by disturbing mechanisms establishing cellu-
lar polarity [7,10]. So far, however, these studies have
used single cells already expressing the oncogene-of-
interest prior to their seeding into matrigel. In stark
contrast, however, carcinomas arise from individual,
somatically mutated cells within the context of an estab-
lished epithelium. Consequently, it would be important
to have a system available in which oncogene expression
can be switched on and off at will during acinar mor-
phogenesis. To the best of our knowledge such a system
does not exist for human mammary epithelial cells, as
has also been noted by others [11]. The only exceptions
a r er e p o r t sb yt h eM u t h u s w a m ya n dB r u g g el a b o r a -
tories, which have used genetically modified ErbB recep-
tors, which can be activated by coumermycin-induced
dimerization. Although extremely informative, this sys-
tem has limitations as it requires the oncoprotein of
interest to tolerate the fusion partner and it relies on
the fact that the activation of the protein in question
occurs upon dimerization. Similarly, fusion proteins
between a modified ligand-binding domain of the estro-
gen receptor (ER) and the protein of interest have been
used in MECs to control the activity or subcellular loca-
lization of a protein of interest as it has been reported
for the catalytic domains of Akt or Raf-proteins
[9,12,13]. However, these approaches, despite the fact
that they respond rapidly to the inducer 4-hydroxyta-
moxifen [4-HT], are often hampered by a certain degree
of leakiness, e.g. due to partial degradation of the fusion
protein, and are also potentially limited by the presence
of the ER domain. Here, we report the generation and
application of a versatile MCF-10A subline, which
allows the tightly regulated and efficient expression of
any oncogene of interest. Using B-Raf and its oncogenic
form (B-Raf
V600E) as a model oncoprotein, we also pro-
vide an example as to how these cells and their trans-
gene expression level can be efficiently monitored and
tracked in real time.
Results
Generation of a stable MCF-10A cell line containing an
improved Tet-regulated expression system
We decided to apply a novel version of a tetracycline
(Tet) -inducible expression system to MCF-10A cells.
Therefore, we transfected the MCF-10AecoR subline
[14] with pWHE644 [15], a vector expressing a tri-cis-
tronic transcript encoding (i) a second generation Tet-
regulated transcriptional transactivator (rtTA2
S-M2)
lacking background activity and with increased sensitiv-
ity towards its effectors, like the tetracycline derivative
doxycycline (dox) [16], (ii) a transcriptional silencer
(tTS
D-PP) with improved reactivation of gene expression
in the presence of effectors (Danke et al., manuscript in
revision) and (iii) puromycin acetylase as selection mar-
ker (Figure 1A). This expression cassette ensures that
the rtTA2
S-M2 and tTS
D-PP proteins are efficiently co-
expressed in puromycin-resistant cells, thereby providing
tight regulation of artificial promoters with tetO ele-
ments responsible for Tet-binding (Figure 1B) [17]. This
combination of Tet-responsive proteins ensures tight
repression of transgene expression in the absence of the
inducer without compromising the responsiveness of the
tetO element containing construct [15]. A direct com-
parison of the novel regulatory system with the pre-
viously used containing a KRAB-based trans-silencer
[18] revealed even tighter regulation in Jurkat cells,
which contained stably integrated transregulators and
which were transiently transfected with a Tet-responsive
reporter plasmid (Additional data file 1). Furthermore,
we have chosen the MCF-10AecoR subline as it allows
the efficient infection with ecotropic retroviruses [14],
which is a useful aspect for the subsequent introduction
of additional transgenes. MCF-10AecoR cells stably
transfected with pWHE644, termed MCF-10Atet in the
following (Figure 1C), were then analyzed for transgene
expression by Western blotting (Figure 1D). MCF-
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Page 2 of 13Figure 1 Establishment of a Tet-regulated expression system for MCF-10A cells. (A) Schematic representation of pWHE644 and (B) pTET/
HAhBRAF-IRES-GFP-bsr. In the absence of dox, the activator protein (yellow) displays no DNA binding activity and the repressor protein (red)
binds to the expression vector, suppressing expression of the gene-of-interest. Upon dox treatment, the repressor looses, while the activator
gains DNA binding activity and drives the transcription of the bi-cistronic HA-B-Raf-IRES-GFP mRNA. See Methods for further details. (C) Flow
chart for the generation of Tet-inducible MCF-10A cell lines. (D) Western blot analysis for screening purposes showing the expression of both
transregulator proteins in a series of independent MCF-10AecoR pools transfected with pWHE644 (MCF-10Atet). A lysate from K562 cells (Wöhrle
et al, in preparation) expressing the rtTA and tTS proteins serves as positive control (K562-pWHE644). Parental MCF-10AecoR cells and mock
transfected K562 cells serve as negative controls. Detection of AKT serves as loading control. Pool 19 was chosen for further evaluation and
ultimately for transfection with the pTET-bsr constructs (E) Morphological comparison of MCF-10AecoR cells (a/b) and the cell pool 19
expressing the rtTA/tTS proteins (c/d) in the subconfluent state and grown to confluency, respectively. (F) Phenotypic comparison of parental
MCF-10A cells [55] in 3D culture with three independent sublines of MCF-10Atet cells (sublines will be explained in detail below) at day 15. Note
that all four sublines form acini displaying ongoing luminal clearance as indicated by the high number of cells stained with an antibody for
cleaved caspase-3.
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S-M2 and tTS
D-PP
expression were further characterized to ensure that
properties, like their susceptibility to ecotropic retro-
viruses (data not shown), the maintenance of their
epithelial character (Figure 1E) and their ability to gen-
erate proper acini in 3D culture were not affected (Fig-
ure 1F). The latter aspect was investigated using a
staining for cleaved caspase-3, which reports luminal
apoptosis, a key event in acinar development integrating
various morphogenetic processes [1,7].
The Ser/Thr-kinase B-Raf represents an important sig-
naling element of the Ras/Raf/MEK/ERK pathway
[19,20]. This signaling cascade is often dysregulated in
human cancer and was recently identified as the com-
mon denominator of signaling pathways associated with
breast cancer risk in a genome wide association study
[21]. Furthermore, although mutations in the RAS or
BRAF genes are rarely observed in the overall majority
of breast cancers, they occur more frequently in cell
lines derived from basal type breast cancers, a rare, but
difficult to treat subtype [22,23]. The importance of this
pathway for this tumor entity is also illustrated by
recent findings showing that basal type breast cancer
cell lines are particularly susceptible towards growth
inhibition by MEK inhibitors [24]. As we have pre-
viously shown that B-Raf signaling influences various
aspects of MCF-10A biology [25], we decided to explore
the role of B-Raf in these cells in more detail and tested
the suitability of our inducible expression system using
this proto-oncogene product. To this end, a representa-
tive population of the MCF-10Atet cells fulfilling the
aforementioned criteria was transfected with either the
plasmid pTET/HAhBRAF-IRES-GFP-bsr or pTET/HAh-
BRAF
V600E-IRES-GFP-bsr (Figure 1C). The latter
encodes for the most common B-Raf oncoprotein found
in human tumors [26], while the former encodes for
wildtype B-Raf (B-Raf
wt). Given the potency of
BRAF
V600E to transform MCF-10A cells in 2D and 3D
culture [25], this oncogene is ideally suited to test the
tightness and reversibility of our conditional system in
2D and 3D culture. Both vectors respond to dox admin-
istration with the expression o fab i - c i s t r o n i ct r a n s c r i p t
encoding hemagglutinin-tagged human B-Raf (HAhB-
Raf) and green fluorescent protein (GFP) (Figure 1B).
The GFP fluorescence allows for the identification of
dox-responsive cells and for sorting cell populations
with desired transgene expression levels as described
previously [14]. In addition, we transfected cells with
pTET/GFP-bsr as an empty vector control. Stably trans-
fected clones were then characterized in terms of leaki-
ness and responsiveness to dox. First, we determined
the optimal dox concentration by performing dose-
response experiments. To this end, we used MCF-
10Atet cells transfected with either the “empty” pTET/
IRES-GFP or the pTET/HAhBRAF-IRES-GFP-bsr con-
structs, as we have shown previously that the expression
of B-Raf
wt and GFP is well-tolerated in MCF-10A cells
and does not induce dramatic phenotypic alterations as
B-Raf
V600E [ 2 5 ] .A ss h o w ni nF i g u r e2 A ,t h ee x p r e s s i o n
of the HAhBRAF-IRES-GFP cassette is efficiently
repressed in the absence of dox. This was also con-
firmed using highly sensitive anti-HA and GFP antibo-
dies in Western blot analyses (Figure 2C/D). However,
dox concentrations as little as 0.02 μg/ml induce trans-
gene expression, while concentrations from 0.2 μg/ml
induce an almost complete induction of transgene
expression. We also noticed that a higher dox concen-
tration did not further increase transgene expression
levels, which is in agreement with dose-response curves
established in HeLa cell lines stably transfected with
rtTA2
S-M2 (Ref. [16]). One potential advantage of con-
ditional gene expression systems is that the level of the
transgene can be titrated using various concentrations
of the inducer compound. At a first glance, however,
the data in Figure 2A suggest that our system behaves
rather switch-like. Nevertheless, upon closer inspection,
we noticed that cells responding to 0.02 μg/ml dox dis-
play a mean GFP fluorescence about half a log unit
lower than those exposed to 0.2 μg/ml dox. These data
indicate that, within certain limits, graded transgene
expression can be achieved as it was also demonstrated
with the pWHE644 plasmid in Jurkat T [15] and CaCo-
2 cells (data not shown). Next, we evaluated the tem-
poral kinetics of transgene expression. As shown in Fig-
ure 2B, GFP expression could be already detected 3 h
following dox exposure and reached a plateau about 24
h later. Interestingly, the mean GFP fluorescence at 6 h
was roughly ten times lower than that at 24 h, which
means that different expression levels can be also
achieved by distinct exposure times.
Another important advantage of reversible, conditional
gene expression systems is that they can be used to
study the decay of the protein-of-interest and the asso-
ciated biological consequences. Thus, we asked whether
transgene expression could be efficiently reversed by
dox wash-out. Therefore, MCF-10A cultures were trea-
ted with dox for 24 h and then subjected to dox with-
drawal. As indicated in Figure 2C, both transgene
products of pTET/HAhBRAF-IRES-GFP-bsr disappear
over the following days indicating that this system is
very suitable to study protein decay rates. A Western
blot analysis of the phosphorylation status of MEK, the
direct substrate of B-Raf revealed that the induction of
B-Raf or its oncogenic form resulted in a strong activa-
tion of this pathway (Figure 2D). Furthermore, its phos-
phorylation in the absence of dox or following wash-out
was not elevated in cells harboring the pTET/HAh-
BRAF-IRES-GFP-bsr plasmids, which, given the potency
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Figure 2 Characterization of Tet-regulated transgene expression in MCF-10A cells. (A, B) FACS analysis showing a typical (A) dose-
response and (B) time course experiment. (C) MCF-10Atet cells stably transfected with pTET/HAhBRAF-GFP-bsr were induced with dox for 24 h
followed by a wash-out of dox. Transgene expression was monitored by Western blotting. (D) MCF-10Atet cells were induced with dox for 24 h
and either kept under dox treatment for additional 6 days (+ 6 days) or subjected to a dox wash-out (wo 6 days). Cells were lysed and Western
blot analysis was performed using the indicated antibodies.
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V600E, further supports our notion that this
expression system is tightly controlled. Most impor-
tantly, the activity of this pathway could be reversed by
dox withdrawal within 6 days. Taken together, our data
clearly show that MCF-10Atet cells represent a tightly
controlled, but still highly efficient gene expression sys-
tem that can be used to manipulate signaling pathways
in a dynamic manner.
Conditional B-Raf
V600E expression in 3D cultures of MCF-
10A cells reveals the plasticity of the transformed
phenotype
Next, we sought to apply the inducible system to study
how oncogenes affect the acinar morphogenesis of
MCF-10A cells in 3D culture (Figure 3A). We have pre-
v i o u s l ys h o w nt h a to n c o g e n i cB - R a f
V600E induces the
epithelial-to-mesenchymal transition (EMT) of MCF-
10A cells and therefore, if expressed ap r i o r i ,p r e v e n t s
acinar morphogenesis [25]. Consequently, we asked as
to how the sudden expression of B-Raf
V600E would
impinge on later stages of acinar morphogenesis and
homeostasis. Therefore, MCF-10Atet cells stably trans-
fected with pTET/HAhBRAF
V600E-IRES-GFP-bsr plas-
mids were seeded into matrigel as described previously
[8] and cultivated for 10 days (Figure 3B). In the
absence of dox, cells harboring the indicated plasmids
developed into regular acini characterized by radial sym-
metry and a thin, polarized and, based on previous work
[7,14] and analyses shown below, most likely growth-
arrested, epithelium consisting of a single cell layer.
However, if the developing acini were exposed to dox
from day 10 onwards, drastic morphological changes
were observed over the next fortnight. The structures
appeared very dense and optical sections using confocal
laser scanning microscopy confirmed the absence of a
lumen (Figure 3D). This indicates that acinar morpho-
genesis is disrupted by either unrestrained proliferation
and/or reduced programmed cell death as it will be con-
firmed below. Importantly, some B-Raf
V600E expressing
cells also protrude from the former acinus into the
matrigel indicating that evading cells have destroyed the
basal lamina (Figure 3B), which is being deposited from
day 4 onwards [7]. Indeed, the typical laminin V coat,
which marks the basal surface of MCF-10A acini and
was supposedly deposited before dox exposure, is dis-
rupted by GFP positive, B-Raf
V600E expressing cells (Fig-
ure 3C). This highly abnormal, invasive phenotype was
present in more than 94% of GFP-positive acini (Addi-
tional data file 2). In full agreement with our earlier
study showing that constitutive expression of B-Raf
V600E
leads to a drastic reduction of E-Cadherin expression
and the induction of other EMT hallmarks [25], we
observed that inducing expression of this oncogene in
10 day old acini resulted in a loss of E-Cadherin
expression in GFP-positive cells (Figure 3D). In contrast,
acini harboring this oncogenic transgene, but not
exposed to dox, develop into regular, symmetric, hollow
and E-Cadherin positive structures, which are compar-
able to acini formed by doxycycline-treated cells trans-
fected with the empty pTET/-IRES-GFP-bsr plasmid.
This indicates that the corruption of acinar structure
and development observed in the dox-treated, B-
Raf
V600E expressing cells can be attributed to the effect
of the oncoprotein and does not represent a side effect
of doxycycline or GFP expression. Furthermore, it
should be noted that acini, which harbor the BRAF
V600E
transgene but were not exposed to dox, are in the same
size range as the empty vector control acini and of com-
parable morphology. Given the profound effects of this
oncogene on acinar development, this observation
further indicates that our dual rtTA2
S-M2/tTS
D-PP
expression system is tightly controlled. This notion is
also strongly supported from our Western blot analysis
showing the absence of HA-B-Raf and GFP in untreated
3D cultures (Figure 3E).
Lastly, we were interested as to whether these pro-
found changes in acinar homeostasis and development
could be reversed by dox withdrawal. Consequently,
MCF-10A cultures, which had been exposed to dox and
displayed invasive behavior, were subsequently cultured
in medium lacking dox. During the following days, we
observed by visual inspection that the GFP expression
disappeared, as one would anticipate based on our
wash-out experiments in 2D culture (Figure 2C/D).
Importantly, we noticed that signs of invasive cell beha-
vior were less frequently observed over time and that
acinar structures increasingly regained a smoother
appearance and a more regular morphology. Twenty-
four days following wash-out, the overwhelming major-
ity of structures progressively resembled mature MCF-
10A acini (Figure 4A), which eventually displayed pro-
minent E-Cadherin deposition at baso-lateral cell-cell
junctions again (Figure 3D). This indicates that the
EMT inducing effect of B-Raf
V600E is reversible. How-
ever, we also observed that, as a result of the B-Raf
V600E
driven increase in cellularity, these acinar structures
were often enlarged, irregularly shaped and contained
many nuclei in the re-developing lumen. Importantly,
many of these nuclei displayed the typical morphology
of fragmented nuclei derived from dead or dying cells,
as it has been described for this model system pre-
viously [7]. In order to get more insight into the redeve-
lopment process of acini following the withdrawal of B-
Raf
V600E, we stained 3D cultures grown in the absence
or presence of dox as well as those subject to our induc-
tion/wash-out protocol with markers for proliferation
(Figure 4B) and cell death (Figure 4C). Using KI-67,
whose expression is strictly associated with cell
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Page 6 of 13Figure 3 Conditional Tet-regulated transgene expression in 3D cultures of MCF-10A cells. (A) Overview on acinar development based on
[1,7]. At day (d) 0, single MCF-10A cells are seeded into matrigel. Apico-basal polarization and luminal cell death occur after one week in culture.
Two weeks later, hollow acini are surrounded by a thick, mostly single cell layer epithelium. During the third week, proliferation ceases, while the
epithelium becomes thinner. (B) Expression of B-Raf
V600E in mid-term acini perturbs their morphogenesis. At d10, one culture was continued in
the absence of dox, while the other was grown in the presence of dox for 14 days. (C). The basal lamina of MCF-10A acini is disrupted by cells
expressing oncogenic B-Raf
V600E. Thirty-three days old acini grown in the presence of dox for 17 days were fixed and stained with an antibody
for laminin V. Note the diffuse laminin V deposition surrounding cells expressing B-Raf
V600E (indicated by an arrow). (D) Dox withdrawal leads to
a loss of invasive structures and reappearance of E-Cadherin. Three D cultures of MCF-10A cells harboring a dox-inducible B-Raf
V600E oncogene
were seeded and switched to dox-containing medium at day 17 for 18 days. Then, dox was withdrawn from one culture (dox wash-out), while
the other culture was kept under dox. Following another 24 days, the cultures were fixed and stained with anti-E-Cadherin antibodies (red) and
Topro-3 (blue) to identify cell-cell contacts and nuclei, respectively. (E) Western blot analysis of 3D cultures showing tight regulation of the
rtTA2
S-M2/tTS
D-PP expression system. MCF-10A cells harboring the inducible B-Raf
V600E or empty vector control constructs were induced at day 6
after seeding and harvested 4 days later.
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Page 7 of 13Figure 4 Dox withdrawal restores acinar architecture of B-Raf
V600E transformed acini. (A) Micrographs of MCF-10A acini harboring a B-
Raf
V600E transgene in the absence (left), presence (middle) and following removal of dox (right panel). Representative phase contrast (upper row)
and fluorescence (lower row) micrographs were taken at day 59. Each micrograph was taken using a 10x objective. Note the enlarged diameter
of the acini in which B-Raf
V600E is or has been expressed. Note also the absence of invasive cells and the reappearance of a regular acinar
architecture in acini following dox wash-out (right panel). (B) Representative confocal microscopy sections of 53 days old acini stained with the
proliferation marker KI-67 (pink). (C) Representative confocal microscopy sections of 53 days old acini stained with the apoptotic marker cleaved
Caspase-3 (pink). In both B and C, the nuclei were stained with Topro-3 (blue). Acini grown in the presence of dox appear green due to the
expression of the GFP reporter.
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Page 8 of 13proliferation [27], we show that late stage acini contain-
ing the “empty” pTET/-IRES-GFP-bsr control construct
display hardly any KI-67 positive cells. This finding is in
full agreement with previous studies on MCF-10A cells
reporting the suppression of proliferation in mature
acini [7,9,14,28,29] and further illustrates that MCF-
10Atet cells and their sublines retain the typical charac-
teristics of their MCF-10A and MCF-10AecoR predeces-
sors. In sharp contrast, acini of MCF-10Atet/cells
transfected with pTET/HAhBRAF
V600E-IRES-GFP-bsr
and exposed to dox display not only the abnormal mor-
phology described above, but contain many KI-67 posi-
tive cells randomly scattered across the colony. Upon
dox wash-out, however, KI-67 positive cells are hardly
observed and only within those structures that still dis-
played higher degrees of irregularity (Figure 4B). This
indicates that there are correlations between the mainte-
nance of B-Raf
V600E expression, cell cycle progression
and the restoration of acinar organization.
A previous study within the MCF-10A system has
shown that luminal filling or the failure of luminal clear-
ance is not only caused by stalled anti-proliferative pro-
grams, but also by the loss of luminal apoptosis [9].
Therefore, we also analyzed the extent of cell death
using an antibody detecting the cleaved, activated form
of caspase-3, a master regulator of apoptosis [7]. As
shown in Figure 4C, MCF-10Atet cells transfected with
the empty vector or with pTET/HAhBRAF
WT-IRES-
GFP-bsr display a large number of apoptotic cells in
their presumptive lumina, regardless as to whether they
have been exposed to dox or not at the time of fixation.
In contrast, MCF-10Atet cells expressing B-Raf
V600E dis-
play some apoptotic cells scattered within the disinte-
grating acinus, but lack the display of a synchronized
apoptosis in the lumen. These data are in agreement
with the anti-apoptotic role of B-Raf
V600E [30] and sug-
gest that luminal filling occurs in acini expressing this
oncogene as a consequence of increased proliferation
and impaired luminal apoptosis. However, as soon as B-
Raf
V600E is withdrawn, the luminal apoptosis program,
which depends on the establishment of apico-basal
polarity and the coordination of intra- as well as supra-
cellular signaling events [1,10,31-33], is restored (Figure
4C). Taken together, our findings demonstrate that the
transformed 3D phenotype of B-Raf
V600E expressing
acini can be efficiently reversed following the withdrawal
of the oncogenic signal and that the morphogenetic pro-
gram of acinus formation can be restored in late stage,
highly disorganized MCF-10A acini.
Discussion
Oncoproteins are dominant-positive acting versions of
“cellular decision makers” that usually control cellular
growth, survival, proliferation and differentiation.
Consequently, the appearance of an oncoprotein often
leads to a drastically distorted intracellular signaling net-
work and an altered cellular phenotype. The conversion
of a relatively immotile, epithelial cell into a highly
motile mesenchymal cell with new features such as stem
cell-like properties during EMT is a prime example for
such a trans-differentiation process [3,34,35]. While
EMT is regarded as a plastic and dynamic event during
embryogenesis, the plasticity and reversibility of such
cell fate alterations in tumorigenesis remains a matter of
debate ([36,37] and references therein). So far, onco-
genes have been mainly studied in the context of tumor
cell initiation, but with the discovery of phenomena
such as “oncogene addiction” and with the increasing
portfolio of drugs targeting oncoproteins, a crucial ques-
tion is how important the persistence of oncogene
expression is for the maintenance of the transformed
phenotype. In order to tackle this question, oncogene
expression systems that can be regulated at will are of
utmost importance for biomedical research.
By applying a novel and tightly controlled tetracycline-
regulated gene expression system to MCF-10A cells, we
believe that we have further improved this important
model system, which is frequently used to study epithe-
lial cell biology and early carcinogenic events alike.
Firstly, this system allows the analysis of the presence/
absence of the gene of interest in an isogenic setting.
Thus, within the same genetic background, cells expres-
sing high or low levels of the protein of interest can be
compared with cells expressing no transgene product at
all. Consequently, artefacts caused by clonal variability
can be avoided. Furthermore, by establishing the MCF-
10Atet line and our sequential transfection protocol
(Figure 1C), we provide a model system, which can be
used to generate several sublines in parallel that express
various genes of interests independently. As such sub-
lines are derived from the same parental cell line, this
approach will allow for a better comparison of research
results with previous experiments or with the work
from other laboratories.
It should be noted that conditional systems have been
implemented in MCF-10A cells before and have pro-
vided novel insights into the function of oncogenic
receptor tyrosine kinases (RTKs). In this experimental
setting, RTKs were fused with dimerization domains
that can be cross-linked by an artificial ligand. However,
this system relies strongly on the principle that RTKs
often use dimerization as a mechanism for activation
[28,38]. Similarly, a fusion protein consisting of a modi-
fied estrogen receptor (ER) binding domain and the iso-
lated kinase domain of Raf-1 (ΔRaf-1:ER) has been used
to activate the ERK pathway in the MEC lines MCF-
10A and T4-2 [12,13] as well as in many other cell
types [39,40]. As Raf-kinases are auto-inhibited by
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domain [25,41], this fusion protein becomes constitu-
tively and rapidly active upon 4-HT- or b-estradiol-
mediated dissociation of the Hsp90 chaperone complex
from the ER moiety and confers constitutive MEK/ERK
signaling [39]. Thus, in the conditional systems employ-
ing ligand-induced RTK dimerization or exposure of a
Raf-1 kinase domain, the proteins under scrutiny are
expressed constitutively and must tolerate the fusion
partner, e.g. a dimerization or ER domain. Furthermore,
as in the case of 4-HT controlled Raf proteins [39,40],
this strategy often requires the removal of large regula-
tory domains involved in auto-inhibition and other pro-
cesses. Consequently, these modified proteins cannot
exert the whole set of intra- and intermolecular interac-
tion events like their full-length counterpart. With our
inducible gene expression system, however, we can now
provide a system that allows the expression of proteins
lacking any modification, which is an important advan-
tage for the conditional expression of cytoplasmic or
nuclear proteins. While our manuscript was in prepara-
tion, Chen et al. reported the conditional expression of
MLK3 in 3D cultures of MCF-10A cells using the
ARGENT transcriptional regulation technology using
the compound AP21967 (Ariad) as an inducer of gene
expression [42]. As this system is independently regu-
lated from the tetracycline-controlled expression system
established in our study, one could envisage that the
combinatorial use of both systems will allow the genera-
tion of MCF-10A cells harboring both systems. This
would give cancer researchers additional flexibility to
model multi-step oncogenesis and to delineate the coop-
eration of oncogenes.
Using B-Raf
V600E as a model oncogene, we have further
substantiated that aberrant Raf-signaling counteracts
lumen formation and confers invasive properties to
MECs grown in 3D culture. We provide evidence that
the impaired lumen formation in B-Raf
V600E expressing
cells results most likely from the combination of a lack of
proliferative suppression in late stage cultures and the
failure to induce systematic luminal apoptosis. Our
observations are in full agreement with previous studies
showing that increased MEK/ERK signaling in 3D cul-
tures of MCF-10A cells blocks luminal clearance by pre-
venting the function and expression of the pro-apoptotic
BIM protein, a critical regulator of acinar morphogenesis
[43,44]. This notion is also in agreement with the obser-
vation that B-Raf
V600E is a potent suppressor of BIM in
colorectal cancer models [30]. Likewise, the invasive
properties are in line with our previous observation that
constitutive expression of this oncoprotein induces EMT
in MCF-10A cells [25] and with a report showing
increased cellular motility in MCF-10A cells expressing
ΔRaf-1:ER [12,45]. Furthermore, a recent report
demonstrated the disruption of acinar architecture by
ΔRaf-1:ER induced matrix metalloproteinase 9 (MMP9)
expression [13]. Despite some phenotypic similarities,
however, we feel that the invasive phenotype induced by
B-Raf
V600E is more drastic than that induced by ΔRaf-1:
ER. Firstly, this oncogenic Raf protein induces a complete
EMT as judged by the loss of E-Cadherin and the gain of
vimentin expression (Figure 2B and Ref. [25]). This was
not observed in MCF-10A cells expressing ΔRaf-1:ER
[12]. Secondly, the acinar structures, in which B-Raf
V600E
has been induced, display an invasive behavior after a few
days in that sense that individual cells protrude into the
matrigel and thus most likely through the basement
membrane (Figure 2C), which is deposited from day 4
onwards [1]. This observation, which was also not
observed in MCF-10A acini expressing ΔRaf-1:ER
[12,45], implies the induction of proteolytic processes by
aberrant Raf signaling. This notion is also in line with the
finding that MMP9 is a target of the Raf/MEK/ERK path-
w a y[ 1 3 ]a n dg i v e nt h a tB - R a fi saf a rm o r ep o t e n tE R K
activator than Raf-1 [39], it is conceivable that MCF-10A
cells expressing oncogenic B-Raf produce higher levels of
proteases compared to ΔRaf-1:ER expressing ones. Thus,
it is not surprising that the disruption of acinar architec-
ture, which is observed in MECs expressing ΔRaf-1:ER
[12,13], is drastically exacerbated in MCF-10A cells
expressing oncogenic B-Raf. These findings might also
contribute to our understanding of the mechanisms by
which aberrant Ras/Raf/MEK/ERK signaling is involved
in the biology of basal type breast carcinomas [22,23].
Conclusions
In conclusion, we have established an MCF-10A cell line
fitted with a novel and tightly controlled tetracycline-
regulated gene expression system. We believe this has
further improved the application range of MCF-10A
cells, an important model system to study epithelial cell
biology and early carcinogenic events alike, for the fol-
lowing reasons: Firstly, this system allows the analysis of
effects caused by the presence or absence of the gene-
of-interest in an isogenic background and therefore
avoids artifacts caused by clonal variability. Secondly,
transgene expression can be efficiently reversed by dox
withdrawal and consequently this system can be used to
address the plasticity of the observed phenotype. Hence,
these MCF-10Atet cells represent an important tool to
understand phenomena such as EMT, oncogene addic-
tion, oncogene-induced senescence and drug resistance.
Methods
Cell lines and tissue culture
Parental MCF-10A cells were obtained from the stock
collection at the Garvan Institute of Medical Research,
Sydney, and represent an early passage population from
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Page 10 of 13an import from ATCC. Its subline, MCF-10AecoR (a
kind gift of Drs. Danielle Carroll and Joan Brugge; Har-
vard Medical School), has been described by various
assays and in detail before [14,25,44,46-48]. MCF-10Atet
cells were generated by transfecting MCF-10AecoR cells
with the AhdI-linearized expression vector pWHE644,
which uses the EF-1a promoter [49] to express a tri-cis-
tronic transcript encoding the tetracycline-regulated
transcriptional activator rtTA2
S-M2, the Tet-transsilen-
cer tTS
D-PP as well as a puromycin resistance gene
[15]. Details of the construction of pWHE644 will be
presented elsewhere (Danke et al., manuscript in revi-
sion). The cell lines in this study were generated by
transfecting MCF-10AecoR or MCF-10Atet cells (2 ×
10
7/700 μl) in hypo-osmolar electroporation buffer
(Eppendorf) with 30 μg AhdI-linearized plasmid DNA
by three electroporation pulses, each separated by a 1
min interval, using an Eppendorf multiporator set at
750 V and 70 μS. However, we have recently noticed
that nucleofection of 2 μg AhdI-linearized plasmid DNA
and program T-024 using solution T (Amaxa) gave bet-
ter transfection efficiencies than conventional electro-
poration (data not shown). Regardless of the
transfection method, the cells were placed under selec-
tion using the appropriate antibiotics (puromycin
(Sigma): 1.5 μg/ml; blasticidin S (Roth): 6 μg/ml) follow-
ing a recovery period for 24 h in conventional growth
medium. MCF-10A cells were set up for 3D culture
experiments as described previously [14,25]. Fixation
and staining of 3D cultures with the antibodies specified
below was performed as described previously [14,25].
Dox dose-response and time-course experiments
Dose-response experiments as shown in Figure 1D were
carried out to identify the optimal dox concentration.
MCF-10Atet cells stably transfected with either pTET-
GFP-bsr (vector) or pTET-HA-B-Raf-GFP-bsr encoding
HA-tagged B-Raf
wt were plated and allowed to adhere
for 24 h. Subsequently, the cells were incubated with
the indicated dox concentrations. After 24 h, they were
harvested by trypsinization and subjected to FACS ana-
lysis using a CyAN cytometer (Beckman-Coulter) and
standard gating procedures to exclude non-viable cells.
Time-course experiments were set up as described for
dose-response experiments using a dox concentration of
2 μg/ml. At the indicated time points, the cells were
harvested and analyzed by FACS.
Expression constructs
In order to generate an expression vector allowing the
simultaneous, dox-inducible expression of hemaggluti-
nin-tagged human B-Raf (HAhB-Raf) and green fluores-
cent protein (GFP), the HAhBRAF-IRES-GFP cassettes
were amplified by PCR from the retroviral pMIG/
HAhBRAF
wt or pMIG/HAhBRAF
V600E expression vec-
tors [50] using oligonucleotides matching regions 5’ and
3’ of this cassette and the proof-reading polymerase
Phusion (Finnzymes). These oligonucleotides introduce
each a NotI site into the PCR amplicon. The PCR ampli-
cons were then subcloned into the cloning vectors
pBSSK+ or pSCA-Amp/Kan (Stratagene) for further
propagation. The subcloned amplicon was then recov-
ered by NotI digestion and subcloned into NotI-linear-
ized pTET-bsr. This plasmid is derived from pWHE636
and contains as novel features a NotI site in its multi-
cloning site and a loxP-flanked blasticidin S resistance
(bsr) cassette derived from pAloxP-bsr [51]. pWHE636
is based on the Tet-response vector pUHD10-3 (Ref.
[52]) and contains, instead of the original promoter
PTRE, the second generation promoter PSG-TRE (Ref.
[53]) to drive expression of a cDNA encoding EGFP-
mut2 (Ref. [54]). Detailed cloning procedures, as well as
plasmid sequences, are available upon request. In brief,
pWHE636 was digested with NcoIa n dBamHIt o
remove the existing EGFPmut2 cassette and the stag-
gered cuts in the vector backbone were blunted by Pfu
polymerase treatment. Subsequently, the vector was re-
ligated and a NotI site was introduced downstream of
the CMV minimal promoter by conventional site-direc-
ted mutagenesis PCR. Subsequently, a loxP-flanked blas-
ticidin S resistance gene cassette under the control of
the chicken b-actin promoter was excised from pAloxP-
bsr [51] by BamHI digestion, blunted by Pfu-polymerase
treatment and subcloned into the MfeI-linearized,
blunted pWHE636 backbone to yield pTET-bsr.
Antibodies, biochemical analysis and Western blotting
Two D and 3D cultures of MCF-10A cells were pro-
cessed to total cellular lysates and analyzed by Western
blotting as described previously [25]. Lysates from 3D
cultures were prepared using the Becton Dickinson (BD)
cell recovery solution. Antibodies used in this study
were anti-E-Cadherin (clone 36; BD Transduction
Laboratories, Heidelberg, Germany), anti-phospho-MEK
(pMEK), anti-MEK1/2, anti-phospho-p42/44 (pERK),
anti-Akt, anti-cleaved Caspase-3 (Asp175) (from Cell
Signaling Technologies, Frankfurt, Germany) anti-b-
Actin (C4), anti-a-Tubulin (from Santa Cruz Bio-
technologies, Santa Cruz, CA, USA), anti-HA antibody
3F10, anti-GFP (from Roche Molecular Bioscience,
Mannheim, Germany), anti-human Epiligrin (Laminin
V) (Millipore, Schwalbach, Germany), anti-KI-67 (clone
MIB-1; from Dako) and the secondary antibodies Alexa
Fluor
® 546 goat anti-rabbit IgG, Alexa Fluor
® 488 goat-
anti rabbit IgG and Cy3 goat anti-mouse IgG (from
Invitrogen, Darmstadt, Germany). The polyclonal anti-
body against the Tet-transregulators was generated in-
house in the laboratory of Dr. Christian Berens.
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FACS-analysis was performed to measure GFP expres-
sion in cells transfected with IRES-based bicistronic vec-
tors. Cells were harvested by standard trypsinization [8]
as described previously. The pellet was resuspended in
300 μl FACS buffer (phosphate-buffered saline supple-
mented with 3% fetal calf serum and 0.1% sodium
azide). GFP fluorescence was examined by flow cytome-
try using a CyAN ADP flow cytometer (Beckman-Coul-
ter). The 488 nm laser was used for excitation and
fluorescence was detected in channel FL-1, respectively.
Additional material
Additional file 1: Regulatory properties of the cell lines Jr2
SM2K
and Jr2
SM2PP. Jurkat cells were stably transfected with pWHE459 or
pWHE644 resulting in the regulator lines Jr2
SM2K and Jr2
SM2PP, both
expressing the transactivator variant rtTA2S-M2 and either the
transrepressor tTS
D-KRAB or tTS
D-PP, respectively. To test their respective
regulatory capacity, single-cell clones of each cell line were transiently
transfected with 800 ng pUHC13-3, coding for firefly luciferase under Tet-
control. For each cell line, three well-regulating clones are depicted
above. The basal luciferase activity obtained in likewise transfected Jurkat
cells not containing any transregulators is shown on the right and serves
as control for repression by tTS and activation of transgene expression
by rtTA.
Additional file 2: Quantification of normal and aberrant MCF-10A
acini. Cells harboring dox-inducible B-Raf
WT, B-Raf
V600E and vector control
constructs were seeded into matrigel, induced at day 17 and subjected
to dox withdrawal at day 29. Representative micrographs were taken at
day 59. At least 34 acini were counted and categorized into non-invasive
phenotype and invasive phenotype (minimum three cells protruding
from the acinus).
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3D: Three dimensional; 4-HT: 4-hydroxy-tamoxifen; BSR: Blasticidin S
resistance, CMV: Cytomegalovirus; DCIS: Ductal carcinoma in situ; Dox:
Doxycycline; EGFP: Enhanced green fluorescent protein; EMT: Epithelial-to-
mesenchymal transition; ER: Estrogen receptor; ERK: Extracellular signal-
regulated kinase; FACS: Fluorescence activated cell sorter; GFP: Green
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